It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
Biocompatible Electric Current Attenuates HIV Infectivity
William D. Lyman, Ph.D., Irwin R. Merkatz, M.D., Steven G. Kaali, M.D., F.A.C.O.G., Albert Einstein College of Medicine, New York, NY
Steven G. Kaali, M.D., F.A.C.O.G.
New York, New York
Originally posted by bigern
What the hell, I think I'm going to go ahead and order the machine. This is probably a stupid question but they say it kills parasites, bacteria, etc. so would this thing clear up warts?
Originally posted by jjjtir
VneZonyDostupa, the 3 researchers of Yeshiva University's Albert Einstein College of Medicine eventually published their data at a medical journal.
But it was a relatively obscure journal with low circulation at the time.
It is not clear whether the editorial board of the journal at the time in 1996 had him or changed since, but the current board does have Steven G. Kaali among the editors.
According to Google Scholar, it was cited only 1 time.
Some honest independent philanthropist has to step up with courage to provide funding, money, to replicate and revive interest in this, it deserves more than only 1 citation.
Originally posted by VneZonyDostupa
reply to post by nh_ee
Unfortunately, pouring money into science doesn't equate to a faster answer. That's what people continue to misunderstand. Science isn't a business. The rate limiting step is not income, but brain-power. If a laboratory has limitless resources, but is facing a seemingly insurmountable problem, it's still going to take long, long time to come up with an answer.
Once these drugs are discovered, the pharmaceutical companies buy the patents and do the clinical testing. THIS is where the bias and lack of publishing comes in.
The idea that science in general is a "business" shows a complete lack of understanding of how university research works.
The vast majority of basic science research doesn't produce a patentable device or drug. Most of it is meant to further our understanding of medicine, biology, biochemistry, etc.
Originally posted by arpanet
Dostupa, I can talk about whatever part of "medical science" I want, whether it be the industrial research or university research, because the topic being discussed is simply "medical science" and that doesn't make me the confused one in this equation. Just because you have chosen to talk about the "basic science research" aspect of medical science doesn't make you confused that we are still talking about medical science does it?
I believe you are under the impression that this juncture is where pharmaceutical companies start pumping money into the research, and that universities providing "basic science research" are not involved in the business. I am afraid pharmaceuticals fund even the "basic science research" by funding the universities too. For instance Pfizer granted Stanford $3 million in this year alone.
I think the only complete lack of understanding is the "business" aspect of university research on your part.
That is great in theory but if this were true then corporations like Pfizer would be pissing their money away, and if we know anything about corporations is that they don't value losing money So I am afraid your words are severely deafened by the actions of pharmaceutical interests....
Originally posted by VneZonyDostupa
Basic science research is where drugs are created. This thread is about medical science research, which is an incorrect term. There is no such thing as "medical science research". There is basic science research, and clinical research. That was the point I was making.
Just to put things in perspective, a $1 million NIH grant for basic research is considered a small grant which is not enough for a year of work in a decent university level lab. If all you can come up with is a single $3 million grant, I'm afraid you'll be disappointed when you look into what a small amount of research dollars that is.
Really? Can you point to any specific point, or are these more of you "last ditch ad hominems"? I've pointed out specific statements of yours anytime I've criticized your understanding. It would be nice if you would do the same, unless they truly are just baseless name-calling.
The largest expense in the pharmaceutical industry is research and development of drugs that never reach market. More drugs reach clinical testing than succeed clinical testing. Of course, all the money spent on those drugs is seen as "wasted" to us, but to Pharma, it is an investment. If you have ten potential new drugs, you spend $500 million testing all of them, and only one succeeds, that might seem to be a bad investment. But when a single drug can make on the order of tens of billions in it's patent exlcusivity lifetime, it's actually quite a nice investment.
Originally posted by arpanet
I understand the point you were making, but the term we are using to encompass both basic science research and clinical research for medicine is: medical science. That being the science that is involved in medicine, and just because you think this is an incorrect term doesn't mean it is...
That is great but $1 million is smaller than $3 million (last time I checked) and the $3 million is just for this year so far. Now I know that actually looking at the points doesn't help your Bill o'Reily dance around the subject but I am going to stop replying if your going to continue missing the obvious points to ridicule examples. The $3 million is an example, the main point is that pharmaceuticals fund Universities is that understood?
My apologies I wasn't aware that you were blind to the "elephant in the living room" as my whole last post was about your lack of understanding that even basic science research is funded by pharmaceutical corporations constituting a business transaction and thereby making "medical science" in both aspects of research a business. That is what this whole conversation has been about mind you.
Again this is great stuff if only it pertained to what I was actually talking about. Nobody is arguing about the largest expense of pharmaceuticals, or anything you just covered about R&D. The only thing that could pertain to what I was talking about would be the return investment except I was talking about the return investment for funding universities where as your talking about return investments for R&D for which I already covered in the post where you thought I was confused...
The bottom line being that pharmaceuticals invest in every aspect of "medical science" whether it be industrial, universities, medical journals, etc... not because it is the right thing to do, but because they are looking for the return investment. Thus by definition making a business out of science.
As for your cute comments about me needing to do more research before I talk, the only thing I have to say is that a true master acknowledges the fact that he will always be a student. You think you have things figured out, and while you stop learning; things are changing and your left behind. I am constantly learning (even from you) and forever expanding my knowledge, and while what you say about me needing more research might be true I would suggest you take a look in the mirror and apply...
This is absolutely true, you're just attacking the wrong target. Pharma companies have little to no influence in basic science research. Once it gets to clinical trials, THAT is where you see pharma influence.
The bottom line being that pharmaceuticals invest in every aspect of "medical science" whether it be industrial, universities, medical journals, etc... not because it is the right thing to do, but because they are looking for the return investment. Thus by definition making a business out of science.
This is absolutely true, you're just attacking the wrong target. Pharma companies have little to no influence in basic science research. Once it gets to clinical trials, THAT is where you see pharma influence.